Skip to content

主角治疗

US · PTGX #1570 按市值排名 上市于 2016
128.75 -7.80 -5.71%
实时 - 追踪5344个代码 - 心跳于24秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量增加了4家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
119.77% -0.06pp
机构数量
428 +4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund80.25%
Hedge Fund25.78%
VC/PE Fund5.91%
Public Company4.69%
Private Company1.40%
Government Pension Fund0.97%
Individual/Insider0.60%
Family Office/Trust0.41%
Insurance Company0.32%

主要股东 截至 2026-06-30

BlackRock 15.93% · 10.31M 股
Farallon Capital Management, L.L.C. 9.81% · 6.35M 股
RTW Investments, LP 7.82% · 5.06M 股
Vanguard Portfolio Management, LLC 5.61% · 3.63M 股
UBS Asset Management 5.42% · 3.51M 股
Wellington Management Group 5.28% · 3.42M 股
State Street Global Advisors 5.13% · 3.32M 股
Vanguard Capital Management, LLC 5.09% · 3.29M 股
Johnson & Johnson Innovation - JJDC, Inc. 3.78% · 2.45M 股
T. Rowe Price Group, Inc. 3.32% · 2.15M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 17次买入 · 33次卖出

姓名职务持股比例
Dinesh Patel CEO, President, Secretary & Director 0.44%
Harold Selick Independent Chairperson 0.09%
Arturo Molina Chief Medical Officer 0.02%
Bryan Giraudo Independent Director 0.02%
Sarah O’Dowd Independent Director 0.01%
William Waddill Independent Director 0.01%
Lewis Williams Independent Director 0.01%
Asif Ali Executive VP & Chief Financial Officer 0.00%
Suneel Gupta Chief Development Officer --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-29 Asif Ali Executive VP & Chief Financial Officer Derivative Exercise and Sale -58,629 $12.17–141.78
2026-09-09 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -125,000 $21.58–146.18
2026-09-02 Dinesh Patel CEO, President, Secretary & Director Other Disposition -510 --
2026-08-10 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -100,000 $21.58–149.11
2026-06-22 William Waddill Independent Director Derivative Exercise and Sale -9,000 $16.54–117.94
2026-06-09 William Waddill Independent Director Derivative Exercise and Sale -9,000 $11.80–107.68
2026-05-28 William Waddill Independent Director Derivative Exercise and Sale -9,000 $11.80–99.64
2026-05-11 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -75,000 $21.58–100.12
2026-05-07 Bryan Giraudo Independent Director Open Market Disposition -23,130 $100.00–100.07
2026-05-06 Bryan Giraudo Independent Director Derivative Exercise and Sale -36,000 $6.45–100.14
2026-04-22 Dinesh Patel CEO, President, Secretary & Director Other Disposition -1,460 --
2026-04-19 Asif Ali Executive VP & Chief Financial Officer Open Market Disposition -1,750 $105.47
2026-03-25 Harold Selick Independent Chairperson Derivative Exercise and Sale -24,000 $12.88–105.00
2026-03-25 Arturo Molina Chief Medical Officer Derivative Exercise and Sale -15,000 $8.04–104.79
2026-03-25 Asif Ali Executive VP & Chief Financial Officer Derivative Exercise and Sale -24,765 $12.17–104.24
2026-03-24 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -54,700 $8.58–101.00
2026-03-22 Dinesh Patel CEO, President, Secretary & Director Other Disposition -50,000 --
2026-02-16 Lewis Williams Independent Director Derivative Exercise and Sale -18,000 $10.84–82.42
2026-02-05 William Waddill Independent Director Derivative Exercise and Sale -20,000 $8.31–83.68
2026-01-26 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -48,273 $4.21–84.59

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

主角治疗 讨论区 0 条评论

发表评论